The sensitivity of the double-labeled panel to stage I HCC was 78.26%, higher than that of alpha-fetoprotein (AFP) 47.83%, and the sensitivity to a single tumor (size ≤ 3cm) was 70.27%. This evidence concerns the gene AFP and hepatocellular carcinoma.